Project Grant R21AG086869
- This $2,991,725 Project Grant award, provided by the National Institute on Aging (CFDA 93.866 Aging Research), supports research into the role of reactive oxygen species as modulators of lifespan and age-related diseases. The 4-year project, which commenced on September 1, 2025, aims to investigate a novel longevity paradigm in C. elegans that is triggered by early-life oxidative stress and mediated by changes in the epigenetic landscape. The research will examine the conserved mechanisms...
- This $1,044,855 Project Grant from the National Institute on Aging, part of the Department of Health and Human Services, will fund Nemalife Inc. to deliver high-throughput testing of anti-aging and FDA-approved drugs in genetically diverse invertebrate Alzheimer's disease models. Under the Aging Research program (CFDA 93.866), the awardee will screen 300 anti-aging compounds and 200 FDA drugs to identify candidates that improve neuronal aging and protect against protein misfolding diseases...
- This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $551,986.00 to The Jackson Laboratory to develop an explainable unified AI strategy for efficient and robust integrative analysis of multi-omics data from heterogeneous longevity studies. The goal is to identify protective genetic variants associated with exceptional human longevity, which can inform therapeutic interventions to improve human health. The 2-year project aims to: 1) create...
- This federal Project Grant award of $1,875,196.00 from the National Institute on Aging (CFDA 93.866 Aging Research) aims to investigate the genetics of exceptional longevity in the ocean quahog, the world's longest-living animal. The research will study genome-wide patterns of selection related to lifespan variation within and across bivalve species, with a focus on the ocean quahog. By leveraging this natural experiment in extreme longevity, the project seeks to identify core physiological...
- This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $416,625.00 to Saint Louis University to conduct research on "Targeted Modulation of Longevity-Associated Genes Using Antisense Oligonucleotides." The project aims to: 1) design and test antisense oligonucleotides to modulate the levels of four longevity-associated genes, and 2) test if the antisense oligonucleotides can extend lifespan and improve healthspan using a mouse...
- This Project Grant award of $660,908 was provided by the National Institute on Aging (CFDA 93.866, Aging Research) to Brandeis University. The project aims to expand on previous research demonstrating that certain circular RNAs (circRNAs) can regulate lifespan and health span. Specifically, the research will: 1) determine the mechanisms behind circRNAs that promote aging, 2) examine the extent and requirements for circRNA translation and its relationship to aging, and 3) define the...
- This $146,922 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research at the University of Southern California to investigate methods for purging mammalian cells of deleterious mutations in the mitochondrial genome (mtDNA) that contribute to aging and age-related diseases. The research aims to develop new genetic and molecular biology tools, combined with advanced sequencing techniques, to selectively remove harmful mtDNA mutations from...
- This Project Grant award of $506,404.00 was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) to investigate mechanisms of local and global epigenetic changes that drive senescence and aging-associated phenotypes. Key research objectives include: Examining how enhancers are rewired during senescence and aging, focusing on large enhancer communities or "cliques" and identifying transcription factors that drive their formation....
- The Research Foundation of the City University of New York (RFCUNY), acting as the fiscal administrator for the City University of New York (CUNY), has received a $458,510 Project Grant award from the National Institute on Aging under the Aging Research program (CFDA 93.866). This award will support the development of a transformative deep learning framework to integrate multi-omics data and elucidate the molecular mechanisms underlying exceptional longevity (EL). The key objectives are to: 1)...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) to The Washington University in the amount of $245,434 is for the development of a novel hybrid viral vector system for therapeutic CRISPR insertion of multiple transgenes. The goal is to create a chimeric adenovirus-adeno-associated virus (AdAAV) gene editing delivery system that can efficiently deliver CRISPR-Cas gene editing machinery and multiple genetic payloads to facilitate the treatment of a...
GENOME ENGINEERING FOR A NOVEL POST-REPRODUCTIVE GENETIC SCREEN FOR INCREASED LONGEVITY - PROJECT SUMMARY THE DISCOVERY OF THE FIRST MUTATIONS KNOWN TO INCREASE LONGEVITY A LITTLE MORE THAN THIRTY YEARS AGO REVOLUTIONIZED THE FIELD OF AGING RESEARCH. DESPITE THEIR FUNDAMENTAL IMPORTANCE, IT HAS BEEN NOTORIOUSLY DIFFICULT TO SCREEN FOR PRO-LONGEVITY MUTATIONS DIRECTLY BECAUSE BY DEFINITION THE EFFECTS OF THE MUTATION CANNOT BE KNOWN UNTIL LATE IN LIFE, AND VERY OLD ANIMALS TEND TO NOT BE ABLE TO REPRODUCE. CROSSES BETWEEN INDIVIDUALS HAVE LONG BEEN FUNDAMENTAL TO GENETICS, BOTH BECAUSE THAT IS WHAT IS NEEDED TO MAP AND IDENTIFY A GIVEN MUTATION AND ALSO BECAUSE REPRODUCTION IS KEY TO PROPAGATING THE MUTATION AFTER IT IS INITIALLY FOUND. THERE ARE STRATEGIES SUCH AS FAMILY SELECTION TO COMPENSATE FOR THIS, BUT THEY TEND TO BE HIGHLY LABORIOUS AND LOW THROUGHPUT. HERE, WE PROPOSE TO BUILD UPON A COMPREHENSIVE GENETIC LIBRARY TRANSGENESIS APPROACH THAT WE HAVE CREATED CALLED "TRANSGENIC ARRAYS RESULTING IN DIVERSITY OF INTEGRATED SEQUENCES" (TARDIS) TO CREATE A CAS9 RNA GUIDE SYSTEM THAT WILL ALLOW COMPREHENSIVE WHOLE GENOME TARGETED MUTAGENESIS IN AN ANIMAL MODEL FOR THE FIRST TIME. TARDIS PROVIDES THE BENEFITS OF LIBRARY-BASED TRANSGENESIS THAT IS FREQUENTLY USED IN MICROBIAL SPECIES, BUT CAPITALIZES UPON THE ABILITY OF THE MODEL NEMATODE CAENORHABDITIS ELEGANS TO PRODUCE AND PROPAGATE EXTRA CHROMOSOMAL ARRAYS. ELEMENTS OF THE ARRAY ARE PULLED AT RANDOM INTO A SINGLE LANDING PAD SITE IN THE GENOME, CONSTRUCTED SO AS GENERATE A SELECTABLE MARKER UPON GUIDE INTEGRATION. THIS SYSTEM HAS THE ADVANTAGE OF ALLOWING THE ENTIRE GENOME TO BE TARGETED USING A CURATED SYNTHETIC LIBRARY IN A DEFINED AND REPRODUCIBLE MANNER. BUT MORE IMPORTANTLY FOR LONGEVITY SCREENS, BECAUSE THE GUIDE IS FOUND AT A WELL-DEFINED LOCATION IN THE GENOME, THE RESULTING MUTATION CAN BE IDENTIFIED VIA SIMPLE SEQUENCING OF A SINGLE SITE IN A SINGLE INDIVIDUAL. REPRODUCTION IS THEREFORE NOT NECESSARY TO MAP OR PROPAGATE THE MUTATION. THIS SYSTEM THEREFORE PROVIDES AN APPROACH FOR THE FIRST FULLY COMPREHENSIVE SCREEN OF PRO-LONGEVITY MUTATIONS IN AN ANIMAL MODEL. SPECIFICALLY, WE AIM TO (1) DEVELOP THIS NEW LIBRARY BASED MUTAGENESIS SYSTEM WITHIN C. ELEGANS, AND (2) USE THIS SYSTEM TO SCREEN FOR NOVEL MUTATIONS THAT INCREASE INDIVIDUAL LONGEVITY. MUTATIONS IDENTIFIED IN THIS FASHION WILL BE CONFIRMED VIA RECAPITULATING THE SAME GENETIC CHANGE IN A STANDARDIZED LINE VIA CRISPR GENOME EDITING, ALLOWING FOR A COMPREHENSIVE ANALYSIS OF THE MUTATIONS EFFECTS ON LONGEVITY. THIS PROJECT WILL CREATE A WHOLLY NEW APPROACH FOR SCREENING FOR MUTATIONS FOR ANY POST-REPRODUCTIVE PHENOTYPE, AS WELL AS ANY MUTATION THAT PRECLUDES REPRODUCTION PER SE. IT WILL ALSO PRODUCE A NEW SET OF GENETIC LINES CONTAINING PRO-LONGEVITY MUTATIONS. BOTH OF THESE OUTCOMES SHOULD BE OF BROAD BENEFIT TO THE GENETICS AND AGING RESEARCH COMMUNITY.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $18.6k | 4/28/25 | ||
| Not listed | $167.6k | 3/7/25 | ||
| Not listed | $167.6k | 3/7/25 | ||
| Not listed | $223.5k | 4/23/24 | ||
| Not listed | $223.5k | 4/23/24 |